Farmers Trust Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-43,972
Closed -$3.21M 166
2023
Q3
$3.21M Sell
43,972
-17
-0% -$1.36K 0.74% 50
2023
Q2
$3.66M Buy
43,989
+270
+0.6% +$22.6K 0.78% 45
2023
Q1
$3.33M Buy
43,719
+12,150
+38% +$1.01M 0.73% 49
2022
Q4
$2.62M Buy
+31,569
New +$2.56M 0.59% 53

Other funds holding XBI

Farmers Trust Company's XBI Position: Q4 2023 in Review

Farmers Trust Company sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2023, closing a stake of 43,972 shares — an estimated $3.21M sold.

Farmers Trust Company first reported a position in XBI in Q4 2022 and held it in 4 quarters. The position peaked at $3.66M in Q2 2023. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

  • Farmers Trust Company reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2023 after selling out during the quarter.
  • Farmers Trust Company sold 43,972 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $3.21M.
  • Farmers Trust Company first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and held it in 4 quarters.
  • Farmers Trust Company's State Street SPDR S&P Biotech ETF position peaked at $3.66M in Q2 2023.
  • 745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on Farmers Trust Company's 13F filing for Q4 2023, filed 9 Jan 2024.